Rapid Dose Therapeutics Corp.DOSE.CN

Health Care · Pharmaceuticals, Biotechnology & Life Sciences · CSE · Canada

Rapid Dose Therapeutics Corp. is a Burlington, Ontario biotechnology company specializing in oral thin-film drug delivery technology marketed as QuickStrip. With development partner Aavishkar Oral Strips Pvt. Ltd. it holds granted Indian patents covering both monolayer and bilayer nicotine oral-film technology and is pursuing international protection through PCT filings.

Key ratios

FCF / Sales

8.2%TTM

2026 -9.8%2025 -55.3%2024 -224.9%

Net margin

-123.1%TTM

2026 -122.2%2025 -259.2%

ROA

-55.2%2026

2025 -148.1%2024 -93.4%

Revenue growth

4.3%TTM

2026 33.0%2025 104.3%2024 42.1%

Recent news

Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy 2026-08-20 · Newsfile

Track DOSE.CN in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer